Patent · US Active

Salts of 7-(2,3-di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic acid as IP receptor agonists

US9174985B2 · kind B2 · utility

1Cited by

1References

9Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Catherine Leblanc · Basel, CH
Stephen Carl McKeown · Stevenage, GB
Anett Perlberg · Gunzgen, CH
Nicola Tufilli

Key dates

Filing date	Jan 11, 2013
Grant date	Nov 3, 2015
Priority date	—
Expiry date	Jan 11, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to salts of (7-(2,3-di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic acid which are useful for treating diseases affected by the activation of the IP receptor, pharmaceutical compositions that contain the salts and processes for preparing the salts are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.